In our previous report, BS downregulated the PD-L1 expression of hepatocellular carcinoma cells and inhibited tumorigenesis by blocking the STAT3 pathway in a mouse model (Zou et al., 2018). The gene discussed is STAT3; the disease is hepatocellular carcinoma.